ORKA — Oruka Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Christopher Graybill Joins Arca As Vice President, Clinical Development
Brief: Arca Biopharma Announces C. Jeff Dekker To Be Appointed CFO
Brief: Arca Biopharma - May Sell Additional Shares Worth Up To $50 Million
Refinitiv Newscasts - Stocks slip as bond yields rise
Brief: Arca Biopharma Inc Files For Mixed Shelf Of Up To $150 Mln
U.S. STOCKS ON THE MOVE-DPW, Ideanomics, Fuel Tech, Renren, oil and gas stocks
U.S. STOCKS ON THE MOVE-DPW, Fuel Tech, Ideanomics, Bellerophon, Niu Technologies
U.S. STOCKS ON THE MOVE-Ideanomics, DPW, Ashford Hospitality, SmileDirectClub
Arca Biopharma: Rises On Fda's 'fast: track' tag for COVID-19 treatment
Brief: Arca Biopharma Q3 Loss Per Share $0.33
U.S. STOCKS ON THE MOVE-Workday, Stable Road Acquisition, RedHill Biopharma, Fox Corp, Disney
Arca Biopharma: Surges On Fda Nod To Begin Potential Covid: 19 drug trial
Brief: Arca Biopharma Announces FDA Approval Of IND Application For Ab201 As A Potential Treatment For Covid-19
Brief: ARCA Biopharma Announces Promotion Of Chief Medical Officer & Vice President, Regulatory Affairs & Quality
Brief: Arca Biopharma Announces Submission Of Ind Application To U.S. FDA For Ab201 As A Potential Treatment For Covid-19
Brief: Arca Biopharma Reports Q2 Loss Per Share $0.73
Brief: Arca Biopharma - Entered Into A Capital On Demand Sales Agreement With Jonestrading Institutional Services Llc
Brief: Arca Biopharma Enters Into Amendment On Demand Sales Agreement With Jonestrading Institutional Services
Brief: ARCA Biopharma Files May Offer & Sell Shares Of Common Stock Of Up To $7.6 Mln